Home » Topics » Collaboration, BioWorld Science

Collaboration, BioWorld Science
RSS

Trillium expands immunology pipeline and enters stem cell field

March 15, 2010

Medivir outlicenses hepatitis B therapeutic MIV-210 to Daewoong

March 12, 2010

BioInvent and Human Genome Sciences enter collaboration for monoclonal antibodies

March 12, 2010

Biomoda and Obio collaborate to expand lung cancer screening program

March 12, 2010

Affymax receives milestone payment from Takeda for phase III Hematide trial in Japan

March 11, 2010

Transgene signs exclusive option agreement with Novartis for NSCLC therapeutic TG-4010

March 11, 2010

Cellzome and GSK enter strategic drug discovery alliance in inflammatory disease

March 11, 2010

Abbott and GSK to develop molecular diagnostic test for skin cancer treatment

March 10, 2010

Harvard and Dana-Farber grant Acetylon exclusive license to HDAC inhibitor discovery platform

March 10, 2010

Omeros licenses Asubio's PDE7 inhibitors for movement disorders

March 10, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 16, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
In the clinic for June 12, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: Anixa, Beone, Bioinvent, Blossomhill, C4, Cellectis, Climb, Elixiron,...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...